Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia

Author： Bucaneve G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.1, 1999-01, pp. : 85-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Teicoplanin in Patients with Acute Leukaemia and Febrile Neutropenia: A Special Population Benefiting from Higher Dosages

By Pea F.  

Clinical Pharmacokinetics, Vol. 43, Iss. 6, 2004-01 ,pp. : 405-415

Adis International

Access to resources Recommend Favorite

Irinotecan: Febrile neutropenia in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

Outpatient treatment of febrile neutropenia is viable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Docetaxel: Neutropenia and febrile neutropenia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Antibacterial Prophylaxis in Patients with Neutropenia

By Segal Brahm H.   Freifeld Alison G.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 2, 2007-02 ,pp. : 235-242

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite